カテゴリ： GlobalData, 中国, 企業調査

Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7849
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：68
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：中国
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism and digestive system, cardiovascular system, blood system, central nervous system drugs, anti-infection, anti-tumor, vaccine and raw material and intermediates. It provides medical diagnostic products such as real time PCR detector, human papillomavirus assay kit, HBV quantitative reagent, and biofosun microorganism identification and susceptibility analysis system. The company’s research and development unit concentrates on therapeutic areas of metabolism and digestive system, blood system, cardiovascular system and central nervous system. Fosun Pharma is headquartered in Shanghai City, Shanghai, China.

Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deal Details 13
Venture Financing 13
Paragon Genomics Raises USD8 Million in Series A Financing 13
Spirometrix Raises USD17.4 Million in Series C Financing 14
Check-Cap Raises Funds through Venture Financing 15
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 16
Private Equity 18
Butterfly Network Raises USD250 Million in Series D Financing 18
Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 19
PBM Capital Acquires Breas Medical From GE Healthcare 21
KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 22
Partnerships 23
Shanghai Fosun Pharma Plans to Form Joint Venture with Fosun International 23
Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 24
Astute Medical Enters into Distribution Agreement with Fosun Long March 25
CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 26
Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 27
Equity Offering 28
Shanghai Fosun Pharma Raises USD331 Million in Private Placement of Shares 28
Gland Pharma May Raise USD500 Million in IPO 30
Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 31
Chindex to Raise USD38.2 Million in Private Placement of Shares 33
Debt Offering 34
Shanghai Fosun Pharma Raises USD190.7 Million in Public Offering of 5.1% Bonds Due 2023 34
Shanghai Fosun Pharma to Raise USD791 Million in Public Offering of Bonds 35
Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 36
Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 37
Acquisition 38
Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 38
Fosun Pharma Acquires 80% stake in Breas Medical 39
Breas Medical Acquires B&D Electromedical 40
Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 41
Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 42
Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For US$250 Million 43
Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 45
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Competitors 46
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Employees 47
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Locations And Subsidiaries 49
Head Office 49
Other Locations & Subsidiaries 49
Recent Developments 50
Strategy And Business Planning 50
Sep 05, 2017: Sisram, the world’s leading medical and medical device company under Fosun Pharma, plans to become the first listed Israeli company in Hong Kong 50
Jul 11, 2017: Rooted in Shanghai innovation Fosun Pharma Zhangjiang new R & D headquarters base was officially launched 52
Financial Announcements 54
Mar 27, 2018: Fosun pharma: Announcement of Final Results for the Year Ended 31 December 2017 54
Oct 31, 2017: Fosun Pharma releases third quarter 2017 revenue up 21.83% YoY Research and development investment continues to increase 56
Aug 30, 2017: Fosun Pharma: R & D and international lighting performance, the first half revenue grew 20.41% 57
Jun 14, 2017: Fosun Pharma released first quarter 2017 revenue up 20.29% R & D investment continued to increase 59
Mar 31, 2017: Fosun Pharma non-net profit in 2016 increased by 26.36% year-on-year Continued to increase innovation and R & D investment Strengthen the layout of medical services 60
Corporate Communications 63
Mar 26, 2018: Change In Fosun Pharma’s Board Of Directors To Further Align Group Strategy 63
Mar 26, 2018: Shanghai Fosun Pharmaceutical Announces Personnel Changes 64
Legal and Regulatory 66
Sep 05, 2017: Fosun Pharmas Subsidiary Sisram, the World’s Leading Energy-Based Medical Aesthetic Treatment Systems Provider, to be Listed as the First Israeli Company on the Main Board of SEHK 66
Appendix 68
Methodology 68
About GlobalData 68
Contact Us 68
Disclaimer 68

List of Tables
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Key Facts, 2017 2
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Deals By Market, 2012 to YTD 2018 9
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Paragon Genomics Raises USD8 Million in Series A Financing 13
Spirometrix Raises USD17.4 Million in Series C Financing 14
Check-Cap Raises Funds through Venture Financing 15
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 16
Butterfly Network Raises USD250 Million in Series D Financing 18
Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 19
PBM Capital Acquires Breas Medical From GE Healthcare 21
KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 22
Shanghai Fosun Pharma Plans to Form Joint Venture with Fosun International 23
Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 24
Astute Medical Enters into Distribution Agreement with Fosun Long March 25
CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 26
Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 27
Shanghai Fosun Pharma Raises USD331 Million in Private Placement of Shares 28
Gland Pharma May Raise USD500 Million in IPO 30
Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 31
Chindex to Raise USD38.2 Million in Private Placement of Shares 33
Shanghai Fosun Pharma Raises USD190.7 Million in Public Offering of 5.1% Bonds Due 2023 34
Shanghai Fosun Pharma to Raise USD791 Million in Public Offering of Bonds 35
Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 36
Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 37
Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 38
Fosun Pharma Acquires 80% stake in Breas Medical 39
Breas Medical Acquires B&D Electromedical 40
Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 41
Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 42
Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For US$250 Million 43
Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 45
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Competitors 46
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employees 47
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Subsidiaries 49

List of Figures
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Energia Argentina SA：電力：M&Aディール及び事業提携情報
    Summary Energia Argentina SA (ENARSA) is a state owned energy company that explores and exploits hydrocarbons in solid, liquid and gaseous states. It stores, transports, distributes, markets and industrializes the hydrocarbons and their derivatives. Energia conducts design, construction, commissioni …
  • Medworxx Inc-医療機器分野：企業M&A・提携分析
    Summary Medworxx Inc (Medworxx), a subsidiary of Aptean Inc is an information technology solution provider that offers software solutions for patient flow, compliance, and education. The company’s software products include patient throughput review software, clinical criteria software, forms and ass …
  • Izumi Co., Ltd.：戦略・SWOT・企業財務分析
    Izumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Izumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Flight Centre Travel Group Limited (FLT)：企業の財務・戦略的SWOT分析
    Flight Centre Travel Group Limited (FLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • TerraForm Power Inc (TERP)：電力：M&Aディール及び事業提携情報
    Summary TerraForm Power Inc (TerraForm Power), formerly SunEdison Yieldco Inc, a subsidiary of Brookfield Asset Management Inc, is an energy development company that owns and operates energy power plants. The company generates and distributes renewable energy by utilizing various clean power generat …
  • Vivimed Labs Ltd (VIVIMEDLAB)：製薬・医療：M&Aディール及び事業提携情報
    Summary Vivimed Labs Ltd (Vivimed) is a supplier of niche molecules and formulations to healthcare, pharmaceuticals and specialty chemicals customers across the world. The company provides active pharmaceutical ingredients (APIs), finished dosage formulations, and specialty chemicals. It manufacture …
  • Oriental Cuisines Private Limited
    Oriental Cuisines Private Limited - Strategy, SWOT and Corporate Finance Report Summary Oriental Cuisines Private Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Policolor SA：企業の戦略的SWOT分析
    Policolor SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • TriVascular Inc：製品パイプライン分析
    Summary TriVascular Inc (TriVascular), a subsidiary of Endologix Inc is a medical device company that researches, designs and manufactures technologies to provide optimal solutions for endovascular aortic repair. The company’s product comprise endovascular grafts and self-expanding stent grafts; ova …
  • Silver Spring Networks, Inc. (SSNI)-エネルギー分野：企業M&A・提携分析
    Summary Silver Spring Networks, Inc. (Silver Spring) is a smart grid networking platform technology and solutions provider. The company’s products include metering devices, network infrastructure, utilityIQ applications, GridScape software and customerIQ web portal. Silver Spring provides wide range …
  • Inter RAO UES (IRAO)：企業の財務・戦略的SWOT分析
    Inter RAO UES (IRAO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • 3I Group Plc
    3I Group Plc - Strategy, SWOT and Corporate Finance Report Summary 3I Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Blount International, Inc.：企業の戦略的SWOT分析
    Blount International, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Maruha Nichiro Corporation
    Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report Summary Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • J Uriach Y Compania SA-製薬・医療分野：企業M&A・提携分析
    Summary J Uriach Y Compania SA (Uriach) is a pharmaceutical company that offers food supplements, cosmetics and OTC products. It also researches, develops and manufactures active ingredients for the pharmaceutical market. Uriach provides antiflatulents, antifungals, mineral supplements and antiplate …
  • EMCOR Group Inc (EME)：企業の財務・戦略的SWOT分析
    EMCOR Group Inc (EME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Atrion Corp (ATRI)：企業の財務・戦略的SWOT分析
    Atrion Corp (ATRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Agios Pharmaceuticals Inc (AGIO)：企業の財務・戦略的SWOT分析
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • Harbour Centre Development Ltd：企業の戦略・SWOT・財務情報
    Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • NEC Corp (6701)：企業の財務・戦略的SWOT分析
    NEC Corp (6701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆